The present study is the first to suggest the possible occurrence of a Ly-EndMT process in the clinically affected skin of patients with SSc, with the lymphatic endothelium representing an additional source of α-SMA+ profibrotic myofibroblasts that can contribute to the pathogenesis of disease-related cutaneous fibrosis. Here, ACTA1 is linked to systemic sclerosis.